Zeke Capital Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $26.3K | Hold |
49,700
| – | – | ﹤0.01% | 468 |
|
|
2022
Q3 | $36K | Hold |
49,700
| – | – | ﹤0.01% | 462 |
|
|
2022
Q2 | $57K | Hold |
49,700
| – | – | ﹤0.01% | 470 |
|
|
2022
Q1 | $102K | Hold |
49,700
| – | – | 0.01% | 500 |
|
|
2021
Q4 | $143K | Hold |
49,700
| – | – | 0.01% | 296 |
|
|
2021
Q3 | $211K | Hold |
49,700
| – | – | 0.01% | 272 |
|
|
2021
Q2 | $263K | Hold |
49,700
| – | – | 0.02% | 257 |
|
|
2021
Q1 | $231K | Hold |
49,700
| – | – | 0.02% | 247 |
|
|
2020
Q4 | $164K | Hold |
49,700
| – | – | 0.01% | 266 |
|
|
2020
Q3 | $165K | Sell |
49,700
-392,404
| -89% | -$1.3M | 0.02% | 220 |
|
|
2020
Q2 | $1.49M | Buy |
442,104
+39,892
| +10% | +$134K | 0.29% | 40 |
|
|
2020
Q1 | $1.54M | Hold |
402,212
| – | – | 0.44% | 31 |
|
|
2019
Q4 | $2.43M | Hold |
402,212
| – | – | 0.2% | 96 |
|
|
2019
Q3 | $3.04M | Sell |
402,212
-9,000
| -2% | -$68K | 0.27% | 76 |
|
|
2019
Q2 | $5.57M | Buy |
411,212
+387,512
| +1,635% | +$5.25M | 0.52% | 34 |
|
|
2019
Q1 | $128K | Hold |
23,700
| – | – | 0.01% | 553 |
|
|
2018
Q4 | $70K | Hold |
23,700
| – | – | 0.01% | 524 |
|
|
2018
Q3 | $193K | Buy |
+23,700
| New | +$193K | 0.02% | 607 |
|
|
2017
Q4 | – | Sell |
-13,600
| Closed | -$114K | – | 621 |
|
|
2017
Q3 | $114K | Buy |
+13,600
| New | +$114K | 0.02% | 419 |
|